Invest now
Supriya Lifescience share price
High risk
You have to be logged in to add this to Watchlist.- ₹915.00(0.51%)September 8, 2026 15:29:20 PM IST
- NSE
- BSE
- Vol : 288.49 K (NSE + BSE)Last 20 day avg : 416.27 K
Supriya Lifescience is trading 0.51% upper at Rs 915.00 as compared to its last closing price. Supriya Lifescience has been trading in the price range of 924.45 & 899.40. Supriya Lifescience has given 20.97% in this year & 13.88% in the last 5 days. There are 1 analysts who have initiated coverage on Supriya Lifescience. There are 0.00 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 24.04 Crores in its last quarter.Listed peers of Supriya Lifescience include Sun Pharmaceutical Industries (-0.98%), Divi's Laboratories (2.85%), Torrent Pharmaceuticals (1.01%).The Mutual Fund holding in Supriya Lifescience was at 1.29% in 30 Jun 2026. The MF holding has decreased from the last quarter. The FII holding in Supriya Lifescience was at 6.18% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 09 Sep 2026, 03:39 AM IST
- BetaHigh volatility1.22Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.00The debt-to-equity ratio, indicating a company's financial leverage.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Dividend Yield-Annual dividends as a percentage of the stock price.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Supriya Lifescience News
Supriya Lifescience Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,881.10 | -0.98 | 4,51,338.90 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,570.55 | 2.85 | 2,54,068.03 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,962.75 | 1.01 | 1,88,760.31 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,383.95 | -0.86 | 1,11,803.57 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,150.00 | -0.43 | 1,14,712.94 | 21.19 | 4.24 | 0.09 | 14.22 |
Mutual Fund Ownership
View allSupriya Lifescience Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-13 | Quarterly Results |
| 2026-05-27 | Audited Results & Final Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
About the company Supriya Lifescience
- IndustryBiotechnology & Drugs
- ISININE07RO01027
- BSE Code543434
- NSE CodeSUPRIYA
Supriya Lifescience Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs). The Company is primarily engaged in the manufacturing of bulk drugs and pharmaceutical chemicals. The Company exports its products in the antihistamine, anesthetics and anti-asthma therapy categories to approximately 86 countries. The Company's product portfolio consists of approximately 38 API products that offer remedies in therapeutic segments, such as antihistamines, analgesics, vitamins, anesthetics and anti-asthmatics, among others. Its products include Chlorphenamine Maleate, Pheniramine Maleate, Brompheniramine Maleate, Dexchlorpheniramine Maleate, Mepyramine / Pyrilamine Maleate, Dexbrompheniramine Maleate, Cetirizine DiHCL, Diphenhydramine HCL, Bisoprolol Fumarate, Nicorandil, Mecobalamin, Hydroxocobalamin Sulfate, Hydroxocobalamin Acetate, and Hydroxocobalamin Hydrochloride, among others. The Company has manufacturing facilities located in Maharashtra.
Supriya Lifescience Share Price FAQs
Supriya Lifescience is trading at 915.00 as on Tue Sep 08 2026 09:59:20. This is 0.51% upper as compared to its previous closing price of 910.35.
The market capitalization of Supriya Lifescience is 7365.39 Cr as on Tue Sep 08 2026 09:59:20.
The average broker rating on Supriya Lifescience is Buy. The breakup of analyst rating is given below -
- 0.00 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Supriya Lifescience is 1085.50 whereas the 52 wk low is 545.65
Supriya Lifescience can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 37.01
- Dividend Yield: %
- D/E ratio: -
Supriya Lifescience reported a net profit of 209.12 Cr in 2026.
The Mutual Fund Shareholding was 1.29% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Supriya Lifescience QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.